APA (7th ed.) Citation

Rosar, F., Khreish, F., Burgard, C., Fursov, A., Blickle, A., Bartholomä, M., . . . Ezziddin, S. (2026). Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting. European Journal of Nuclear Medicine & Molecular Imaging, 53(5), 3034. https://doi.org/10.1007/s00259-025-07682-5

Chicago Style (17th ed.) Citation

Rosar, Florian, et al. "Comparison of MCRPC [177Lu]Lu-PSMA-617 Radioligand Therapy with and Without Concurrent Enzalutamide Medication in a Real-world Setting." European Journal of Nuclear Medicine & Molecular Imaging 53, no. 5 (2026): 3034. https://doi.org/10.1007/s00259-025-07682-5.

MLA (9th ed.) Citation

Rosar, Florian, et al. "Comparison of MCRPC [177Lu]Lu-PSMA-617 Radioligand Therapy with and Without Concurrent Enzalutamide Medication in a Real-world Setting." European Journal of Nuclear Medicine & Molecular Imaging, vol. 53, no. 5, 2026, p. 3034, https://doi.org/10.1007/s00259-025-07682-5.